Paper2519903
RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.
Floch A and 5 others. J Lipid Mediat, 1989. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release. Papers, record 2519903. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2519903
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Volume | Major topic |
| Platelet Activating Factor | Major topic |
| Pyridines | Major topic |
| Thiazoles | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Animals | |
| Dexamethasone | |
| In Vitro Techniques | |
| Lipopolysaccharides | |
| Macrophages | |
| Male | |
| Mice | |
| RNA, Messenger | |
| Rats |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9119469 | A protective role of platelet-activating factor in murine candidiasis. | Infect Immun | 1997 | https://conductscience.org/library/papers/9119469 | PubMed |
| 8719795 | Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/8719795 | PubMed |
| 8423096 | An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan. | Infect Immun | 1993 | https://conductscience.org/library/papers/8423096 | PubMed |
| 7743464 | Clinical experience with platelet-activating factor antagonists. Past, present, and near future. | Clin Rev Allergy | 1994 | https://conductscience.org/library/papers/7743464 | PubMed |
| 7693276 | Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. | Br J Pharmacol | 1993 | https://conductscience.org/library/papers/7693276 | PubMed |
| 7681601 | A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/7681601 | PubMed |
| 1717219 | PAF. A review of its effects, antagonists and possible future clinical implications (Part II). | Drugs | 1991 | https://conductscience.org/library/papers/1717219 | PubMed |
| 1612734 | In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin. | Infect Immun | 1992 | https://conductscience.org/library/papers/1612734 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2519903
GET https://conductscience.org/api/papers/v1/2519903/authors